STOCK TITAN

ACCURAY (ARAY) SEC Filings, Oct-Nov 2026

ARAY NASDAQ

Accuray Incorporated filings document financial results, Regulation FD presentations, governance changes, and material agreements for a radiation therapy systems company. Recent 8-K reports cover quarterly operating results, withdrawal of financial guidance, investor presentation materials, executive appointments and departures, consulting and separation arrangements, and equity-based compensation matters.

The filing record also includes formal disclosure controls and reporting-status matters, including a Form 12b-25 late 10-Q notification and non-reliance disclosures related to remaining performance obligation, or RPO, presentation in revenue footnotes. These filings connect Accuray's public-company reporting to revenue disclosure methodology, audit committee determinations, executive compensation terms, and corporate governance events.

Rhea-AI Summary

Accuray Incorporated will effect a 1-for-40 reverse stock split at 12:02 a.m. Eastern Time on November 9, 2026, after the board selected that ratio from the range of 1-for-15 to 1-for-40 approved by stockholders. Issued and outstanding common shares are expected to fall from approximately 120.2 million to approximately 3.0 million, subject to fractional-share adjustments. Authorized common shares will decline from 400,000,000 to 10,000,000; total authorized capital stock will decline from 405,000,000 to 15,000,000, including 5,000,000 authorized preferred shares, which will not be adjusted.

Each 40 shares held at the effective time will combine into one share. Accuray will pay cash for fractional interests equal to the fraction multiplied by the split-adjusted closing price on the preceding trading day; those interests carry no voting, dividend or other rights except the right to that payment. Subject to the split, the board approved proportionate adjustments to outstanding equity awards, plan reserves and warrants, including share counts and exercise prices. Trading is expected to begin split-adjusted on The Nasdaq Capital Market on November 9 under ARAY. Accuray states that ownership percentages will not change except for fractional-share treatment.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-16.90%
Tags
current report
-
Rhea-AI Summary

Accuray Incorporated (ARAY) reported fiscal 2027 first-quarter revenue of $86.5 million for the three months ended September 30, 2026, down 8% from $93.9 million a year earlier. Product revenue fell 26% to $27.3 million, while service revenue rose 4% to $59.2 million. Gross profit was $26.1 million, or 30.1% of revenue, versus $27.0 million, or 28.8%, a year earlier.

Net income was $10.1 million, including a $59.6 million non-cash gain on debt extinguishment and a $35.4 million non-cash goodwill impairment; excluding both, Accuray reported a $14.0 million net loss. Adjusted EBITDA was $2.5 million versus negative $4.1 million. Gross product orders were $19.8 million versus $39.6 million, and backlog was $272.0 million as of September 30, 2026, approximately 31% lower than at the end of the prior fiscal year’s first quarter. The debt-for-equity exchange remained subject to closing conditions as of September 30, 2026. Accuray continues not to provide formal fiscal 2027 revenue or Adjusted EBITDA guidance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-16.90%
Tags
current report
-
Rhea-AI Summary

Accuray Inc. CEO and director Stephen R. La Neve settled 312,500 restricted stock units for 312,500 common shares on October 31, 2026. In connection with the net settlement, the issuer withheld 100,001 shares to satisfy tax withholding and remittance obligations, at a reported $0.14 per share. The transaction reports 937,500 restricted stock units following settlement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.11%
Tags
insider
Rhea-AI Summary

Accuray Inc. VP, Corporate Controller Michael John Murphy converted 37,500 restricted stock units into 37,500 common shares on October 31, 2026. The issuer withheld 12,001 shares to satisfy tax withholding and remittance obligations in connection with net settlement. The reported derivative position following the transaction was 75,000 restricted stock units. The units vest 25% annually over four years from the grant date. No Rule 10b5-1 plan is reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.11%
Tags
insider
-
ARS
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.16%
Tags
annual report
-
Rhea-AI Summary

Accuray Incorporated (ARAY) will hold its 2026 annual meeting virtually on November 19, 2026, at 11:00 a.m. CT. Holders of common stock as of October 8, 2026 may vote; 119,555,592 shares were issued and outstanding on that date, with one vote per share. The ballot includes Richard A. Meier’s election to a term ending at the 2029 annual meeting, a nonbinding vote on named executive officer compensation, and ratification of Grant Thornton LLP for the fiscal year ending June 30, 2027.

For fiscal 2026, actual orders (net of cancellations) were $192 million against a $288.0 million minimum threshold, revenue was $401.9 million against a $460.0 million threshold, and adjusted EBITDA margin was 2.6% against an 8% threshold. The bonus plan received 0% funding. President and CEO Steve La Neve received a $262,500 minimum annual cash incentive award, and Senior Vice President, Chief Commercial Officer Paul Miele received an $87,000 minimum award under their employment agreements.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.16%
Tags
proxy
Rhea-AI Summary

Accuray Incorporated (ARAY) said Class II director Mika Nishimura will not stand for re-election at the company’s 2026 annual meeting, scheduled for November 2026. She will continue as a director and Chairperson of the Compensation Committee until the meeting concludes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.99%
Tags
current report
-
Rhea-AI Summary

Accuray Inc. granted director Richard A. Meier 75,000 restricted stock units and 75,000 non-qualified stock options on October 5, 2026. Each RSU represents a contingent right to receive one common share. Both awards vest in three equal annual installments beginning on the first anniversary of the grant date. The options have an exercise price of $0.30 per share.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.74%
Tags
insider
-
Rhea-AI Summary

Accuray Inc. (ARAY) director Richard A. Meier reports no securities beneficially owned. No transactions are reported.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.74%
Tags
insider
Rhea-AI Summary

Accuray Incorporated (ARAY) stockholders approved three proposals at the October 6, 2026 special meeting, which the company said would enable completion of its announced transaction with TCW Asset Management Company LLC. The terms include exchanging $40 million of term loan debt for convertible preferred stock, a $15 million equity investment by TCW, access to a delayed draw term loan of up to $5 million, and covenant relief through December 31, 2027.

Stockholders also approved, subject to certain conditions, common-stock issuance tied to conversion of Series A preferred stock and warrant exercises, an increase in authorized common shares from 200,000,000 to 400,000,000, and a reverse-split proposal allowing a whole-number ratio from 1-for-15 to 1-for-40. The board will determine the ratio and timing.

The board appointed Richard A. Meier as a Class II director and Compensation Committee member on October 5, 2026. His compensation includes a $30,000 annual cash retainer, an initial RSU grant for 75,000 shares, and stock options for 75,000 shares, each vesting in thirds over three anniversaries subject to continued service.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.10%
Tags
current report

FAQ

How many ACCURAY (ARAY) SEC filings are available on StockTitan?

StockTitan tracks 99 SEC filings for ACCURAY (ARAY), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for ACCURAY (ARAY)?

The most recent SEC filing for ACCURAY (ARAY) was filed on November 19, 2026.